Genetic signatures expose drug susceptibility in breast cancer cells

A genomics approach has unmasked genetic signatures in breast cancer cells that predict their sensitivity to certain drugs. The findings provide proof of concept for personalized pharmaceutical therapies that target the genes responsible for driving tumor growth.